Submitted by Santy Marques-Ladeira (Institut Curie, France) on May 11 2016
Platform: microarray – [HuGene-2_1-st] Affymetrix Human Gene 2.1 ST Array [transcript (gene) version]
Pubmed: 28490595
Summary Human MDM were exposed to VSVG-pseudotyped HIV-1 NL-AD8 for 8h, 24h, and with HIV-1 + AZT for 24h
ID | Title | Cell Type | Timepoint | Reported Virus | Virus Species | Exclusion Reason |
---|---|---|---|---|---|---|
GSM2150402 | MDM non treated at 8h donor #69 | macrophage | 8 hrs | none | Uninfected | |
GSM2150403 | MDM infected by HIV-1 at 8h donor #69 | macrophage | 8 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150404 | MDM non treated at 8h donor #71 | macrophage | 8 hrs | none | Uninfected | |
GSM2150405 | MDM infected by HIV-1 at 8h donor #71 | macrophage | 8 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150406 | MDM non treated at 8h donor #72 | macrophage | 8 hrs | none | Uninfected | |
GSM2150407 | MDM infected by HIV-1 at 8h donor #72 | macrophage | 8 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150408 | MDM non treated at 24h donor #69 | macrophage | 24 hrs | none | Uninfected | |
GSM2150409 | MDM infected by HIV-1 at 24h donor #69 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150410 | MDM infected by HIV-1 + AZT at 24h donor #69 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | Extra interventions AZT |
GSM2150411 | MDM non treated at 24h donor #71 | macrophage | 24 hrs | none | Uninfected | |
GSM2150412 | MDM infected by HIV-1 at 24h donor #71 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150413 | MDM infected by HIV-1 + AZT at 24h donor #71 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | Extra interventions AZT |
GSM2150414 | MDM non treated at 24h donor #72 | macrophage | 24 hrs | none | Uninfected | |
GSM2150415 | MDM infected by HIV-1 at 24h donor #72 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | |
GSM2150416 | MDM infected by HIV-1 + AZT at 24h donor #72 | macrophage | 24 hrs | HIV-1 | Human immunodeficiency virus 1 | Extra interventions AZT |